Double Drug Delivery Using Capped Mesoporous Silica Microparticles for the Effective Treatment of Inflammatory Bowel Disease.

Teruel AH, Pérez-Esteve É, González-Álvarez I, González-Álvarez M, Costero AM, Ferri D, Gaviña P, Merino V, Martínez-Máñez R, Sancenón F

Open source

DOI: 10.1021/acs.molpharmaceut.9b00041
Published: 2019 Jun 3
Container: Molecular pharmaceutics
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1021/acs.molpharmaceut.9b00041,
  title = {Double Drug Delivery Using Capped Mesoporous Silica Microparticles for the Effective Treatment of Inflammatory Bowel Disease.},
  author = {Teruel AH and Pérez-Esteve É and González-Álvarez I and González-Álvarez M and Costero AM and Ferri D and Gaviña P and Merino V and Martínez-Máñez R and Sancenón F},
  year = {2019},
  journal = {Molecular pharmaceutics},
  doi = {10.1021/acs.molpharmaceut.9b00041},
  url = {https://doi.org/10.1021/acs.molpharmaceut.9b00041}
}

RIS

TY  - JOUR
TI  - Double Drug Delivery Using Capped Mesoporous Silica Microparticles for the Effective Treatment of Inflammatory Bowel Disease.
AU  - Teruel AH
AU  - Pérez-Esteve É
AU  - González-Álvarez I
AU  - González-Álvarez M
AU  - Costero AM
AU  - Ferri D
AU  - Gaviña P
AU  - Merino V
AU  - Martínez-Máñez R
AU  - Sancenón F
PY  - 2019
JO  - Molecular pharmaceutics
DO  - 10.1021/acs.molpharmaceut.9b00041
UR  - https://doi.org/10.1021/acs.molpharmaceut.9b00041
ER  -

APA

AH, T., É, P., I, G., M, G., AM, C., D, F., P, G., V, M., R, M., & F, S. (2019). Double Drug Delivery Using Capped Mesoporous Silica Microparticles for the Effective Treatment of Inflammatory Bowel Disease.. Molecular pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.9b00041

Source records

pubmed · retrieved 2026-09-27T15:04:19.774Z